Peripheral neuropathy refers to neurologic dysfunction that occurs outside of the brain and spinal cord. Patients with cancer are at risk for peripheral neuropathy caused by cancer, treatment, or both. Among patients treated with anticancer therapies known to increase the risk of peripheral neuropathy, 10%–100% will develop the condition. According to the research, peripheral neuropathy can cause pain and other sensory symptoms as well as patient safety concerns because of changes in dexterity, gait and balance problems, weakness, proprioception, and loss of some motor skills.
ONS staff researchers and clinical specialists have exhaustively assessed evidenced-based research from comprehensive sources to provide you our best recommendations on Symptom Interventions for your patients.
ONS account holders enjoy access to more clinical, evidence-based practice information.